ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,574.31
0.13%
US Tech 100
19,862.00
0.08%
Dow Jones
39,534.15
0.40%
Brent Oil
85.94
-0.65%
Bitcoin
55,900.99
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. NovoCure Ltd (NVCR) Quote

NovoCure Ltd

NovoCure Ltd (NVCR)

NASDAQ
16.52
-0.26
( -1.55% )
Updated: 10:12:36
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
16.52
Bid
16.50
Ask
16.54
Volume
88,366
16.44 Day's Range 17.04
10.87 52 Week Range 42.02
Market Cap
1.806B
Previous Close
16.78
Open
16.99
Last Trade
18
@
16.53
Last Trade Time
10:14:43
Financial Volume
$ 1,487,856
VWAP
16.8374
Average Volume (3m)
1,511,164
Shares Outstanding
107,611,077
Dividend Yield
-
PE Ratio
-8.65
Earnings Per Share (EPS)
-1.92
Revenue
509.34M
Net Profit
-207.04M

About NovoCure Ltd

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives it... NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.novocure.com
Headquarters
Jersey, Gbr
Founded
1970
NovoCure Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker NVCR. The last closing price for NovoCure was $16.78. Over the last year, NovoCure shares have traded in a share price range of $ 10.87 to $ 42.02.

NovoCure currently has 107,611,077 shares outstanding. The market capitalization of NovoCure is $1.81 billion. NovoCure has a price to earnings ratio (PE ratio) of -8.65.

NVCR Latest News

More News

Novocure to Report Second Quarter 2024 Financial Results

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management...

July 01 2024
Business Wire

Form 8-K - Current report

June 10 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 06 2024
Edgar (US Regulatory)

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with TTFields therapy and supportive care compared to 11.3 months for patients treated with...

June 03 2024
Business Wire

TIGER-Studie berichtet über neue Überlebensergebnisse der TTFields-Therapie bei neu diagnostizierten Glioblastom-Patienten in Deutschland

Langzeitüberleben bei neu diagnostiziertem Glioblastom wurde in der größten prospektiven, nicht-interventionellen Studie zur Untersuchung der TTFields-Therapie beobachtet Topline-Ergebnisse...

May 24 2024
Business Wire

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

Durable survival effect observed in the largest prospective, non-interventional study completed examining TTFields therapy use in newly diagnosed GBM Topline data to be presented Saturday, June...

May 23 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.75-4.3427909669917.2717.6816.44139085617.02068969CS
4-4.76-22.368421052621.2822.2516.44198412218.08148659CS
122.9221.470588235313.624.73511.7151116418.2378957CS
263.22524.257239563713.29524.73511.7143853516.40656191CS
52-25.44-60.629170638741.9642.0210.87154945218.39144968CS
156-166.03-90.9504245412182.55195.7810.8799828649.28454234CS
260-47.76-74.299937772264.28232.7610.8797069373.57568733CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ZAPPZapp Electric Vehicles Group Ltd
$ 7.2999
(79.36%)
33.4M
MORFMorphic Holding Inc
$ 55.625
(74.70%)
21.03M
SVMHSRIVARU Holding Ltd
$ 0.250301
(57.52%)
78.74M
IVPInspire Veterinary Partners Inc
$ 2.3301
(56.38%)
28.46M
HYWHywin Holdings Ltd
$ 0.4799
(52.35%)
463.49k
HLVXHilleVax Inc
$ 1.8007
(-87.19%)
11.8M
CLEUChina Liberal Education Holdings Ltd
$ 0.79
(-63.76%)
8.31M
SYTSYLA Technologies Company Ltd
$ 2.15
(-29.28%)
199.57k
CJETChijet Motor Company Inc
$ 5.90
(-27.16%)
47.94k
DTCKDavis Commodities Limited
$ 0.9195
(-23.38%)
228.24k
MAXNMaxeon Solar Technologies Ltd
$ 0.3105
(29.38%)
222.17M
SVMHSRIVARU Holding Ltd
$ 0.250301
(57.52%)
78.74M
NVDANVIDIA Corporation
$ 129.9501
(3.27%)
63.55M
CEROCERo Therapeutics Holdings Inc
$ 0.2688
(5.79%)
33.56M
ZAPPZapp Electric Vehicles Group Ltd
$ 7.2999
(79.36%)
33.4M

NVCR Discussion

View Posts
whosleftholdindabag whosleftholdindabag 1 month ago
Another week, another beautiful day for $NVCR shareholders! GLTA
🐀 1 💩 1 🖕 1 🤮 1
whosleftholdindabag whosleftholdindabag 2 months ago
Another beautiful start of the week for $NVCR! GLTA
💩 2 🖕 2 😂 1 🤮 1
KIPK KIPK 2 months ago
LOL - Go from over $200 to $20.
Wondering why this charity worker is NWBO hater.
Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

BUT not this guy??

You judge!!!

KARMA!!
👍️ 2 💯 2
whosleftholdindabag whosleftholdindabag 2 months ago
GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA
🖕 2 ⚠️ 1
whosleftholdindabag whosleftholdindabag 2 months ago
Beautiful day $NVCR! GLTA
👎️ 2 🖕 2 🤣 2
whosleftholdindabag whosleftholdindabag 2 months ago
It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA
👎️ 2 🖕 2 🚫 1 🤣 1
TiltMyBrain TiltMyBrain 2 months ago
Insiders to sell shares in 30 days
👍️ 2 💥 2 🤡 1
KIPK KIPK 2 months ago
LOL 🤣🤣🤣
👍️ 2 💯 1
dstock07734 dstock07734 2 months ago
Or you can simply wait.
👍️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 2 months ago
Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA
🖕 2 🤣 1 ⚠️ 1
dstock07734 dstock07734 2 months ago
By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.
👍️ 4
dstock07734 dstock07734 2 months ago
libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?
👍️ 3 🤣 2
whosleftholdindabag whosleftholdindabag 2 months ago
No, do you? GLTA
🤡 1 ⚠️ 1
whosleftholdindabag whosleftholdindabag 2 months ago
I'd be careful you're getting a wee bit close to libel don't you know? GLTA
🖕 3 🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 2 months ago
Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA
💩 2 🖕 2 🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 2 months ago
You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.
👍️ 1 💩 3 🖕 3
TiltMyBrain TiltMyBrain 2 months ago
Toxic financing for a company who’s price is down 90% in last 3 years
👍️ 2 💥 2
TiltMyBrain TiltMyBrain 2 months ago
Today is the pump. Tomorrow is the insider dump
👍️ 2 💥 2
KIPK KIPK 2 months ago
What a great day right Nemeses 18?
How is dat charity holding da bag???
👍️ 2 😂 2 🤣 1
KIPK KIPK 3 months ago
Gone with the wind on wings of fake therapy IMO
👍️ 2 💩 1 💯 1 🖕 1
KIPK KIPK 3 months ago
20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS
👍️ 1 💩 1 🖕 1
axelvento axelvento 3 months ago
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/
👎️ 2 🤣 1
TiltMyBrain TiltMyBrain 3 months ago
#dcvax $nwbo #gbm

Washinton State's HCA has denied coverage for Tumor Treating Fields, preventing access to this treatment option for Washington Medicaid patients and state employees.

'Optune/Tumor Treating Fields (TTF):
Petition for rereview received. Not selected for… pic.twitter.com/OPPsTyjXhk— Peter Davis (@peter_brit) April 2, 2024

This ship is sinking fast!
👍️ 3 👏 3
TiltMyBrain TiltMyBrain 3 months ago
insider selling in 3...2...1...
👍️ 3 💯 3 😂 1 🤣 1
TiltMyBrain TiltMyBrain 3 months ago
"Preliminary analyses of key secondary endpoints (time to neurocognitive failure, overall survival, and radiological response rate) did not demonstrate statistical significance."

pump and dump in progress
👍️ 2 💯 2 🤡 1 🤣 1
whosleftholdindabag whosleftholdindabag 3 months ago
Loving the early action on $NVCR. Wishing everybody a great day! GLTA
🐀 1 🖕 1 🗑️ 1 🤡 1 🤣 2
KIPK KIPK 3 months ago
LOL - "In time to Intracranial Progression" ??? SMH
👍️ 1 💩 1 🖕 1
Awl416 Awl416 3 months ago
METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
👍️ 2 💯 1
KIPK KIPK 3 months ago
The Vanishing tin can on the wind of ineffectiveness!!
Have a kick at it MATE - LOL !!
👍️ 1 💩 1 🖕 1
KIPK KIPK 4 months ago
You just made a positive post for NWBO without knowing it MATE. Think JAMA.....

And that's So sad as You must be in total loss for words to be citing here a post by a Paid NWBO Basher, InquiriNg. At least you should have given the credit as she, just like you, has been lost for words as well MATE!! . LOL Mate!!

You Birt got nothing & the tin hat is made for a tin man... just like you & the charity investor scamwannabe!!
LOL
👍️ 4 💩 1 🖕 1 🤣 2
jondoeuk jondoeuk 4 months ago
NWBO's DCVax-L is an expensive placebo. The same is true for DCVax-Direct.
👍️ 1 💩 1 💯 1 🖕 1 🗑️ 3 🤮 1 ❌️ 2
KIPK KIPK 4 months ago
Congrats whosbagholding. You keep expanding your reach into Charity Work. LOL - SMH...

Below is a response to one of your good will intention (LOL) on NWBO MB>>>>
Re: AAPL31415926 post# 679357

Monday, March 18, 2024 8:40:02 AM

Post#
679360
of 679363
Amazing that whosbagholding gave me a clown emoji on this comment. It shows how absolutely evil these people are. Hopefully he/she/it/they don't have to face their spouse or one of their children being diagnosed with a fatal disease that they work hard to try and destroy a cure for. Then again there's always karma.
💩 1 🖕 1
KIPK KIPK 4 months ago
Who S Left Hold In D Bag - LOL LOL LOL LOL - Brit Mate?? LOL
👍️ 2 💩 1 🖕 1 🤣 2
KIPK KIPK 4 months ago
Anyone looking for, whosleftholdindabag, the fake charity worker mate (lol), he spends all his time on NWBO MB, fingering up 🖕🏻 (LOL), NWBO paid bashers.
This dude is full of undigested charity food (LOL)
👍️ 3 💥 2 💩 1 🖕 1 😂 1 🤣 1
KIPK KIPK 4 months ago
whosleftholdindabag - LOL, LOL, LOL< LOL👎🏻🤢
👍️ 2 💥 2
KIPK KIPK 4 months ago
whosleftholdindabag - This thing must TOTALLY Believe Survival of NVCR, that he claims invested in for charity, TOTALLY Depends on Death of NWBO, Otherwise why Spending all hours on NWBO MB, supporting NWBO Bashers, while giving 👎🏻 / 🤡 to NWBO Longs???

A charitable character would innately support all companies who are trying to do good & and be a positive difference maker in peoples life! I guess that description is contrary to his motives!!
👍️ 4 💯 2
KIPK KIPK 4 months ago
Poor resentful LOSER....
Rent Free, LOL... I just hate pretenders like you ... MATE?? LOL///
Like lurking Junk yard dog.... as you are..
Bloody Bitter?? who uses that term... ??
Dummy Englishio??
Woof Woof Woof...
Bugger off??? LOL --- How old are you? 100? LOL
👍️ 4 🤣 2
whosleftholdindabag whosleftholdindabag 4 months ago
Why are you so bloody bitter mate? I live rent-free in your head, find a hobby, get a job, and do something useful with your life!

It's a shame about Dr. B. I thought he was a good bloke.

Go back to your other obsession, $NWBO and bugger off!
👍️ 1 💩 3 🖕 1 🤡 1 🤢 1
KIPK KIPK 5 months ago
Hey, whosleftholdindabag. Who is Holding That Big, Fat, Bag?? The Fake Tech is declaring its Fakeness IMO...
Keep adding now!!
👍️ 3 🤣 2
KIPK KIPK 5 months ago
Fake charity investor, whosleftholdindabag, keep lucking around NWBO MB, giving thumbs up to known trash or cash posters & thumbs down to reputable/knowledgeable NWBO investors..

What a waste of a life... SMH
👍️ 3 💩 1 💯 2 🖕 1
dennisdave dennisdave 5 months ago
sure click on the link https://investorshub.advfn.com/boards/replies.aspx?msg=173765065
take the mouse from your mom's computer and move the mouse pointer on your screen (so not the actual mouse in your hand but the one on the screen) to the link (the link is in blue in the post). Click the right button on the mouse in your hand to open the link. Then reread the post. If you dont understand these instructions ask a caregiver to help you.
💩 1 🤢 1
KIPK KIPK 5 months ago
Its so, so, so incredible therapy that its MB see all read/// LOL
💩 1 🖕 1
KIPK KIPK 5 months ago
The poor & Desperate, whosleftholdindabag, spends all his time giving thumbs up supports to any who posts something negative about NWBO, SMH...

What a pretend BS...
👍️ 2 💩 1 💯 1 🖕 1
KIPK KIPK 5 months ago
whoseletholdingabag... LOL.. & LOL big time at you... NVCR is stuck here until it goes to sub1$
👍️ 1 💩 1 💯 1 🖕 1
KIPK KIPK 6 months ago
bottomless pit because the stuff doesn't work as advertised IMO
👍️ 2 💩 1 💯 1 🖕 1
KIPK KIPK 6 months ago
NOoooo, junkoeuk,,,, The NoCure Signals were twisted from the get go.... game over now that the cat out of the hat finally IMO... da update, da rev. no matter what you post... Fact has this down from over 200 to about $10,,, dat should tell you some fact!! LOLing,,,,
👍️ 2 💯 2
jondoeuk jondoeuk 6 months ago
TRIDENT update https://www.businesswire.com/news/home/20240109397768/en/Novocure-Announces-Last-Patient-Enrolled-in-Phase-3-TRIDENT-Trial-in-Newly-Diagnosed-Glioblastoma
👎🏻 2 🤡 1
jondoeuk jondoeuk 6 months ago
Full Year and Fourth Quarter '23 Net Revenues and Company Update https://finance.yahoo.com/news/novocure-announces-preliminary-full-fourth-120000184.html
👍️ 1 👎🏻 2 🤡 1
KIPK KIPK 6 months ago
NoCure Trapping More INVESTORS IMO.. This thing not worth considering at all IMO,,,
A treading stock for those skilled to do it IMO..
💩 1 🖕 1
jondoeuk jondoeuk 6 months ago
Upcoming https://www.biospace.com/article/releases/novocure-to-participate-in-42nd-annual-j-p-morgan-healthcare-conference/
👍️ 1 👎🏻 1

Your Recent History

NASDAQ
NVCR
NovoCure
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved